MARC Record from marc_columbia

LEADER: 03130cam a22003254a 4500
001 7155888
005 20221130212432.0
008 090326s2009 nyua b 001 0 eng
010 $a 2009417121
020 $a9780199234479 (pbk.)
020 $a0199234477 (pbk.)
024 $a99933526564
035 $a(OCoLC)ocn244062812
035 $a(OCoLC)244062812
035 $a(NNC)7155888
035 $a7155888
040 $aDLC$cDLC$dBTCTA$dBAKER$dYDXCP$dBWK$dBWX$dOrLoB-B
050 00 $aRS403$b.P38 2009
100 1 $aPatrick, Graham L.$0http://id.loc.gov/authorities/names/n94082449
245 13 $aAn introduction to medicinal chemistry /$cGraham L. Patrick ; with a chapter on combinatorial and parallel synthesis ; co-authored by John Spencer.
250 $a4th ed.
260 $aNew York :$bOxford University Press,$c2009.
300 $axxii, 752 pages :$billustrations (some color) ;$c27 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tDrugs and drug targets: an overview -- $gPt. A.$tDrug targets -- $g2.$tProteins: structure and function -- $g3.$tEnzymes: structure and function -- $g4.$tReceptors: structure and function -- $g5.$tReceptors and signal transduction -- $g6.$tNucleic acids: structure and function -- $gPt. B.$tPharmacodynamics and pharmacokinetics -- $g7.$tEnzymes as drug targets -- $g8.$tReceptors as drug targets -- $g9.$tNucleic acids as drug targets -- $g10.$tMiscellaneous drug targets -- $g11.$tPharmacokinetics and related topics -- $gCase study 1.$tStatins -- $gPt. C.$tDrug discovery, design, and development -- $g12.$tDrug discovery: finding a lead -- $g13.$tDrug design: optimizing target interactions -- $g14.$tDrug design: optimizing access to the target -- $g15.$tGetting the drug to market -- $gCase study 2.$tThe design of ACE inhibitors -- $gCase study 3.$tArtemisinin and related antimalarial drugs -- $gCase study 4.$tThe design of oxamniquine -- $gPt. D.$tTools of the trade -- $g16.$tCombinatorial and parallel synthesis -- $g17.$tComputers in medicinal chemistry -- $g18.$tQuantitative structure-activity relationships (QSAR) -- $gCase study 5.$tDesign of a thymidylate synthase inhibitor -- $gCase study 6.$tDesign of a serotonin antagonist as a possible anxiolytic agent -- $gPt. E.$tSelected topics in medicinal chemistry -- $g19.$tAntibacterial agents -- $g20.$tAntiviral agents -- $g21.$tAnticancer agents -- $g22.$tCholinergics, anticholinergics, and anticholinesterases -- $g23.$tDrugs acting on the adrenergic nervous system -- $g24.$tOpioid analgesics -- $g25.$tAntiulcer agents -- $gCase study 7.$tCurrent research into antidepressant agents -- $gApp. 1.$tEssential amino acids -- $gApp. 2.$tThe standard genetic code -- $gApp. 3.$tStatistical data for QSAR -- $gApp. 4.$tThe action of nerves -- $gApp. 5.$tMicroorganisms -- $gApp. 6.$tDrugs and their trade names.
650 0 $aPharmaceutical chemistry.$0http://id.loc.gov/authorities/subjects/sh85023026
700 1 $aSpencer, John.$0http://id.loc.gov/authorities/names/n86031233
852 00 $boff,eng$hRS403$i.P38 2009